Novavax and Nucleus partner to launch Covid-19 vaccine trials

Novavax’s Phase I trial of NVX-CoV2373 will begin at Nucleus’ Melbourne and Brisbane clinics in mid-May. Credit: Felipe Esquivel Reed.